Close

NANO WORLD CANCER DAY 2017

This third edition of the Nano World Cancer Day was held in fifteen different countries across Europe. It resulted in a positive and growing interest!

  • More than 75 different great speakers involved, please visit the page Fellow Speakers for more information
  • More than 450 people attended the event, including 70 journalists
  • More than 50 articles and several television reportages


AUSTRIA - GRAZ

Organized by BioNanoNet in close collaboration with Medical University of Graz and NanoMedicine-Austria, the event was held at Graz, at Center for Medical Research.

It was a press conference open to journalists and public including a Q&A-session with national press.

Read more


It was a success with more than 60 people attending including a member of the Austrian Parliament NR-Abg. Univ. Prof. Mag. Dr. Beatrix KARL and a representing Governor of the Province of Styria, LH Hermann Schützenhöfer and 10 journalists.

Find the complete report of the event here.


SPEAKERS

  • Rector Hellmut Samonigg, Medical University of Graz- Official Welcome

  • Sabine Oberhauser, Federal Minister of Health and Women’s Affairs – requested , Jörg Leichtfried, Federal Minister for Transport, Innovation and Technology – requested & Reinhold Mitterlehner, Federal Minister of Science, Research and Economy – requested – Statements

  • ETPN Representative, Introductory presentation of the Nano World Cancer Day 2017 and of the European Technology Platform on Nanomedicine

  • Elisabeth Andritsch, Division of Oncology, Medical University of Graz- Needs in the treatment of cancer patients

  • Michael Speicher, Institute of Human Genetics, Medical University of Graz – Progress through nano-technological development in medicine

  • Berthold Huppertz, Biobank Graz – Improvement by scientific infrastructure for treating cancer

  • Wolfgang Graier or Roland Malli, Next Generation Fluorescence Imaging GmbH – Nano-technological applications in medicine

PRESS COVERAGE

  • one video on ORF television
  • one report on a Austrian radio
  • 5 press articles, 3 are available below
    • Der Standard
    • Humantechnology
    • SCIENCE.


BELGIUM - BRUSSELS

Organized by VITO Vlaamse Instelling voor Technologisch Onderzoek/Flemish Institute for Technological Research in close collaboration with VLAIO Vlaanderen Innoveren & Ondernemen/ Flanders Innovation & Entrepreneurship (VLAIO) and Nano4Health project, the event was held at Brussels.

Read more


SPEAKERS

  • Dr. Inge Nelissen – Flemish Institute for Technological Research (VITO), ETPN representative – Introduction of the Nano World Cancer Day 2017 and of the European Technology Platform on Nanomedicine
  • Mrs. Lieve Apers – Flanders Innovation & Entrepreneurship, Coordinator of the EU project Nano4Health – Nano4Health: How to boost cross sectoral innovation?
  • Prof. Stefaan De Smedt – Ghent University – Targeted therapy with nanomedicines: Small particles, large perspectives
  • Dr. Franky Van Herreweghe – Business Developer, Phoreon: a brand of Pharma Diagnostics NV – The unexpected face of gold: a strong ally in cancer treatment
  • Prof. Inge Mertens – Flemish Institute for Technological Research (VITO), University of Antwerp – The use of extracellular vesicles from plasma and urine in early diagnosis of cancer


GERMANY - FRANKFURT

Organized by Dechema under the aegis of the German NanoBioMedicine Platform, the event took place at Frankfurt.


The event was opened to public and 60 people attended it. Very interesting discussions arose between the audience and speakers from SMEs, Universities and association of patient.

Read more


For more details (in German) about the event go here or here, or upload the flyer.


SPEAKERS AND PROGRAM

  • Prof. Dr. Christoph Alexiou, Universität Erlangen/Nürnberg
  • Dr. Robert Jabulowsky, Senior project manager, BioNTechAG, Mainz
  • Dr. Josbart Metselaar, Pharmaceutical Technology and Translation, RWTH Aachen
  • Ralf Rambach, Federal Association for the Protection of Animals, Bonn
  • Dr. Klaus Michael Weltring, Managing Director of Gesellschaft für Bioanalytik e.V. & Spokerperson of the German NanoBioMedicine Platform


ICELAND - REYKJAVIK

Organized by University of Iceland together with the University Hospital of Iceland, the press conference took place at Reykjavik and was opened to journalists and public. 30 people attended it. The Medor hf. company sponsored the event.

Read more


SPEAKERS AND PROGRAM

  • Berglind Eva Benediktsdóttir , Assistant Professor in Pharmaceutics, University of Iceland
  • Pétur Hannesson, Chief physician, Radiology Unit, The National University Hospital of Iceland
  • Garðar Mýrdal, Head of Radiophysics Unit, Iceland National University Hospital  
  • Már Másson, Professor in Medicinal Chemistry, University of Iceland

PRESS COVERAGE

One of the leading daily press newspaper in Iceland Morgunblaðið, covered the event, find the article here.


IRELAND – DUBLIN

Organized by the Trinity College of Dublin the eventtook place in Dublin.

The event was a press conference gathering a mixed audience from University and hospital.Speakers were from Universities and advisor of government.

Read more


SPEAKERS 

  • Welcome + Introduction to Nanomedicine and Theranostics – Adriele PRINA-MELLO
  • The right tool for the right application – Donnchadha QUILTY
  • Impact of glycosylation at the nanoparticle biological interface, a strory of an acedemic industry alliance – Marco MONOPOLI
  • Translational Medicine overview – Orla SHEILS
  • Development of Diagnostic strategies for prostate cancer patients – Laura MARIGNOL
  • Questions and answers – Open Forum (facilitated A. Prina-Mello)
  • End of the Nano World Cancer Day

PRESS COVERAGE

The media coverage was good with one article published on the most important national journal of medical doctors Medicine News and one radio interview.


ISRAEL - TEL AVIV

Organized by the Tel Aviv University the event tookplace in Tel Aviv and was broadcast  http://video.tau.ac.il/nanocancerday2017

Read more


SPEAKERS AND PROGRAM

  • Prof. Dan Peer – Utilizing nanotechnology for personalized medicine in blood cancers
  • Dr. Noam Shomron – Big data and genomics: halting the spread of breast cancer
  • Dr. Carmit Levy – Bidirectional communication of melanoma with the micro environment

Dr. Ahmi Ben-Yehuda will animate the event.


ITALY - MILAN

Organized by the CEN together with the University of Pavia the event took place in Pavia the press conference was opened to journalists and also scientists, engineers, policymakers and patient representatives.
Read more


SPEAKERS AND PROGRAM

  • Roberto Bottinelli, Professor, Molecular Medicine Dept.,University of Pavia  Introduction 
  • Furio Gramatica, ETPN representative, Professor and Head of Technology Innovation and Health Technology Assessment, Fondation Don Carlo Gnocchi ONLUS and Livia Visai, Professor, Molecular Medicine Dept.,University of Pavia – Nanomedicine in Europe, the ETPN network
  • Romano Danesi, Professor, Clinical Pharmacology andPharmacogenetics, Clinical and Experimental Medicine Dept., University of Pisa – The contribution of nanotechnologies to pharmacological research in oncology
  • Alfonso Gentile, Professor, Country Medical Director, Roche Nanotechnologies and antitumoral therapies: the pharma industry engagement
  • Alberto Ricciuti, President of a patient Association “Attivecomeprima Onlus” –Personalized Therapy and Healthcare relationship 
  • Daniela Ovadia, Scientific journalist, Co-director of the Neuroscience and Society Lab, Brain and Behavioral Sciences Dept. -University of Pavia  Nanomedicine on the press – sources, critical aspects, social impact
  • Livia Visai – Closing remarks

PRESS COVERAGE

Speakers were interviewed on a local radio and 3 articles were issued on several regional and national newspapers: La Provincia, Il Secoloxix and L’Altra Pagina.


NETHERLANDS – UTRECHT

Organized by NanoNextNL together with the Dutch Cancer Society and the Netherlands Organisation for Scientific Research (NOW), the event took place at Utrecht.

The event was open to journalists and public. More than 60 people attended the event and the audience was composed of scientists, engineers, policymakers and patient representatives.

Read more


SPEAKERS AND PROGRAM

  • Dr. Pieter Gaillard, CSO, 2-BBB
  • Robert Geertsma, ETPN representative, National Institute for Public Health
  • Dr. Bennie ten Haken / Dr. Joost Pouw, Associate Professor / Post Doc, Magnetic Detection Group, University Twente
  • Dr. Frank Nijsen, Associate Professor and CSO, University Medical Center Utrechts & Quirem Medical
  • Dr. Gabri van der Pluijm, Associate ProfessorHead of Urology Research Laboratory ,Leiden University Medical Center

INSIGHTS

For more details about the meeting please find a short report here.


POLAND – WARSAW

Organized by Institute of High Pressure Physics of the Polish Academy of Sciences together with Society of Polish Nanomedicine, the press conference was opened to journalists and public and took place at Warsaw. Almost 160 people attended it.

Read more


SPEAKERS AND PROGRAM

  • Agnieszka Chodara, Researcher, IHPP PA
  • Prof. Izabella Grzegory, Director of the Institute of High Pressure Physics of the Polish Academy of Sciences (IHPP PAS)
  • M.D Artur Kowalik, Department of Molecular Diagnostics of The Swietokrzyskie Oncology Center
  • Prof. Witold Łojkowski, Head of Laboratory of Nanostructures, ETPN Representative, IHPP PAS
  • Elżbieta Pietrzykowska, PhD, IHPP PAS
  • Julia Rogowska Tylman, PhD, Warsaw University of Technology
  • Bartosz Woźniak, Research Associate, Laboratory of Nanostructures,
  • M.D Robert Zdanowski, Division for Regenerative Medicine and Cell Biology,Military Institute of Epidemiology and Hygiene


PORTUGAL – BRAGA

Organized by the International Iberian Nanotechnology Laboratory together with TecMinho, the event was held at Braga

Read more


SPEAKERS AND PROGRAM

  • Welcome: Nanomedicine at INL and presentation of the European Technology Platform on Nanomedicine (ETPN)  Lars Montelius, Director General of INL, ETPN representative
  • E-cadherin mutations in cancer: new methods of diagnosis and new molecular partners for treatment  Raquel Seruca, Epithelial Interactions in Cancer Group Coordinator at i3S
  • Nanotechnology in Oncology: dream or reality – Fátima Cardoso, Breast Unit Director at the Champalimaud Clinical Centre
  • Treat U: targeting unmet medical needs with nanomedicine based strategies–João Nuno Moreira CNC – Center for Neurosciences and Cell Biology, FFUC – Faculty of Pharmacy, University of Coimbra

PRESS COVERAGE

The press coverage was good and diverse


SPAIN - BARCELONA

Organized by NanomeSpain and Institute for Bioengineering of Catalonia supported by the Spanish government. the press conference took place at Val D’Hebron Institute of Oncology.  It was opened to jounalists and public.

Read more


SPEAKERS

  • Opening – Prof. Josep Samitier – Scientific Coordinator of the Nanomed Spain & Scientific Director of the Institute for Bioingineering of Catalonia
  • Nanotechnologies at service of patients with cancer – Teresa Lopez-Fando – Projects and Services Coordinator, Spanish Association against Cancer
  • Nano-enabled therapies for cancer: an industrial perspective – Ángel del Pozo – European Projects and Intelectual Property Manager, Biopraxis Resaerch AIE
  • Nanomedicines against Cancer: From Basic Research to Clinical Applications – Prof. Álvaro Somoza Professor Investigator of Nanobiotechnology Group, IMDEA Nanociencia
  • Nanotechnology applied to oncology: a new reality? – Teresa Macarulla – Medical Oncologist, Val d’Hebron Institute of Oncology

PRESS COVERAGE

2 article were issued in one of themost read national newspaper  El Mundo 


SWITZERLAND – ZURICH

Organized by Swiss Federal Institute of Technology and University Geneva the event took place at Geneva, at University Medical Center. The press conference was opened to journalists and public.

Read more


SPEAKERS

  • Introduction and presentation of the European Technology Platform on Nanomedicine (ETPN) –Prof. Emeritus Heinrich Walt – University Hospital Zurich, ETPN Representative
  • Promising potentiel of nanoparticules for theranostic – Prof. Heinrich Hofmann – Director of the Powder Technology Laboratory, Ecole Polytechnique Fédérale de Lausanne
  • Does our immune system cope with the nanoparticules ? – Prof Carole Bourquin – Professor of Pharmacology, University of Geneva
  • Nanoparticules use for a local thermotherapy of tumors – PhD, Olivier Jordan – Senior Lecturer, University of Geneva
  • How to evaluate the nanomedicines efficacy?– Prof. Gerrit Borchard –University of Geneva

INSIGHTS

Please find detail of the event here (In French)


TURKEY- GEBZE

Organized by the Gebze Technical University, the event took place at Gebze. It was a mixed audience composed of 80 people as students, researchers and clinicians.

Read more


SPEAKERS

  • Dr. Fabienne Dumoulin – ETPN representative, Associate Professor, Gebze Technical University
  • Prof. Vefa Ahsen – ETPN representative, Gebze Technical University
  • Prof. Dr. Zafer Gülbaş, MD – Anadolu Medical Center, Istanbul
  • Prof. Dr. IHSAN GURSEL – THORLAB-Therapeutic Oligonucleotide Research Laboratory, Bilkent university, Ankara
  • Assist. Prof. Tolga SütlüSabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul

PRESS COVERAGE


UK - LONDON

Organized byProfiscio together with Endomag, the event took place at the University ofLiverpool in London.  The pressconference was attended with more than 60 people as journalists and public.

Read more


SPEAKERS

  • Examples of application of nanomedicine in cancer – Prof. Khuloud Al-Jamal, Reader in Nanomedicine, Kings College London
  • The use of nanomedicine to enhance radiotherapy treatment of cancer – Dr Gareth Wakefield, Chief Technical Officer at Xerion Healthcare
  • Pioneer Award: Funding revolutionary ideas, faster – Dr. Jess Sutcliffe, Research Funding Manager at Cancer Research UK
  • Accelerating the translation of nanomedicines – Dr Euvian Tan, Expert at Nanomed TAB
  • Dr Dan Gooding, Co-founder of Nuformix
  • Precision Nanomedicines; the best of all possible worlds? – Prof. Andrew D. Miller, Director of KP Therapeutics & Professor at Kings College London